Premium
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
Author(s) -
Nkontchou G.,
Ziol M.,
Aout M.,
Lhabadie M.,
Baazia Y.,
Mahmoudi A.,
Roulot D.,
GanneCarrie N.,
GrandoLemaire V.,
Trinchet J.C.,
Gordien E.,
Vicaut E.,
Baghad I.,
Beaugrand M.
Publication year - 2011
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/j.1365-2893.2011.01441.x
Subject(s) - hepatocellular carcinoma , genotype , medicine , gastroenterology , cirrhosis , hazard ratio , interquartile range , incidence (geometry) , hepatitis c , steatosis , hepatitis c virus , confidence interval , virology , biology , virus , gene , biochemistry , physics , optics
Summary. Liver steatosis is a main histopathological feature of Hepatitis C (HCV) infection because of genotype 3. Steatosis and/or mechanisms underlying steatogenesis can contribute to hepatocarcinogenesis. The aim of this retrospective study was to assess the impact of infection with HCV genotype 3 on hepatocellular carcinoma (HCC) occurrence in patients with ongoing HCV cirrhosis. Three hundred and fifty‐three consecutive patients (193 men, mean age 58 ± 13 years), with histologically proven HCV cirrhosis and persistent viral replication prospectively followed and screened for HCC between 1994 and 2007. Log‐rank test and Cox model were used to compare the actuarial incidence of HCC between genotype subgroups. The patients infected with a genotype 3 ( n = 25) as compared with those infected with other genotypes ( n = 328) had a lower prothrombin activity [78 (interquartile range 60–85) vs 84 (71–195) %, P = 0.03] and higher rate of alcohol abuse (48% vs 29%, P = 0.046). During a median follow‐up of 5.54 years [2.9–8.6], 11/25 patients (44%) and 87/328 patients (26%) with a genotype 3 and non‐3 genotype, respectively, develop a HCC. HCC incidences were significantly different among the genotype subgroups ( P = 0.001). The 5‐year occurrence rate of HCC was 34% (95% CI, 1.3–6.3) and 17% (95% CI, 5.7–9.2) in genotype 3 and non‐3 genotype groups, respectively ( P = 0.002). In multivariate analysis, infection with a genotype 3 was independently associated with an increased risk of HCC occurrence [hazard ratio 3.54 (95% CI, 1.84–6.81), P = 0.0002], even after adjustment for prothrombin activity and alcohol abuse [3.58 (1.80–7.13); P = 0.003]. For patients with HCV cirrhosis and ongoing infection, infection with genotype 3 is independently associated with an increased risk of HCC development.